Clinical outcomes of patients treated using very short duration dual antiplatelet therapy after implantation of biodegradable-polymer drug-eluting stents: rationale and design of a prospective multicenter REIWA registry

被引:7
作者
Ishida, Masaru [1 ]
Takahashi, Fumiaki [2 ]
Goto, Iwao [1 ]
Niiyama, Masanobu [3 ]
Saitoh, Hidenori [4 ]
Sakamoto, Tsubasa [5 ]
Maegawa, Yuko [6 ]
Osaki, Takuya [7 ]
Nishiyama, Osamu [8 ]
Endo, Hiroshi [9 ]
Sakamoto, Ryohei [10 ]
Kojima, Tsuyoshi [11 ]
Koeda, Yorihiko [1 ]
Kimura, Takumi [1 ]
Itoh, Tomonori [1 ]
Morino, Yoshihiro [1 ]
机构
[1] Iwate Med Univ, Div Cardiol, Dept Internal Med, 2-1-1 Idaidori, Yahaba, Iwate 0203695, Japan
[2] Iwate Med Univ, Dept Informat Sci, Div Med Engn, Yahaba, Iwate, Japan
[3] Hachinohe Red Cross Hosp, Dept Cardiol, Hachinohe, Aomori, Japan
[4] Iwate Prefectural Ofunato Hosp, Dept Cardiol, Kitakami, Iwate, Japan
[5] Iwate Prefectural Ofunato Hosp, Dept Cardiol, Ofunato, Japan
[6] Iwate Prefectural Miyako Hosp, Dept Cardiol, Miyako, Japan
[7] Iwate Prefectural Kuji Hosp, Dept Cardiol, Kuji, Japan
[8] Iwate Prefectural Ninohe Hosp, Dept Cardiol, Ninohe, Japan
[9] Iwate Prefectural Iwai Hosp, Dept Cardiol, Ichinoseki, Japan
[10] Nakadori Gen Hosp, Dept Cardiol, Akita, Japan
[11] Morioka Red Cross Hosp, Dept Cardiol, Morioka, Iwate, Japan
关键词
Coronary artery disease; Drug-eluting stent; Dual antiplatelet therapy; Percutaneous coronary intervention; CORONARY; TRIAL; EVENTS; CLOPIDOGREL; THROMBOSIS; COVERAGE; SYSTEM; RISK; THIN; PCI;
D O I
10.1007/s12928-020-00694-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have demonstrated the safety and feasibility of short (3-6 months) and very short duration (< 2 months) dual antiplatelet therapy (DAPT) in patients with a durable-polymer drug-eluting stent (DP-DES). However, the clinical importance of using very short duration DAPT has yet to be established in patients with a biodegradable polymer drug-eluting stent (BP-DES). The aim of this REIWA registry (multicenter and prospective registry; investigation of clinical outcomes of patients treated with short duration dual antiplatelet therapy after implantation of biodresorbable-polymer drug-eluting stent: a multicenter, prospective registry from Iwate medical university affiliated hospitals) is to determine the safety and feasibility of using 1-month DAPT followed by P2Y12 inhibitor monotherapy in patients after BP-DES implantation. This study is an observational, prospective, multicenter registry encompassing the entire local medical region of Iwate Prefecture (northern area of mainland Japan). A total of 1200 patients who underwent successful PCI with a novel thin strut BP-DES (Synergy, Ultimaster or Orsiro) and are considered to be appropriate patients for very short DAPT, are registered and subsequently administered 1-month DAPT followed by P2Y12 inhibitor monotherapy (clopidogrel 75 mg/day or prasugrel 3.75 mg/day). The primary endpoint was a composite of cardiovascular and bleeding events, which included cardiovascular death, spontaneous myocardial infarction, definite stent thrombosis, ischemic or hemorrhagic stroke, or TIMI major or minor bleeding at 12 months. The REIWA registry (UMIN000037321) will demonstrate both the safety and feasibility of using 1-month DAPT in patients with BP-DES. Furthermore, results of this study will also be able to provide supportive evidence for P2Y12 inhibitor monotherapy after 1-month DAPT following BP-DES implantation.
引用
收藏
页码:398 / 404
页数:7
相关论文
共 32 条
[1]   Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents Risk Scores From PARIS [J].
Baber, Usman ;
Mehran, Roxana ;
Giustino, Gennaro ;
Cohen, David J. ;
Henry, Timothy D. ;
Sartori, Samantha ;
Ariti, Cono ;
Litherland, Claire ;
Dangas, George ;
Gibson, C. Michael ;
Krucoff, Mitchell W. ;
Moliterno, David J. ;
Kirtane, Ajay J. ;
Stone, Gregg W. ;
Colombo, Antonio ;
Chieffo, Alaide ;
Kini, Annapoorna S. ;
Witzenbichler, Bernhard ;
Weisz, Giora ;
Steg, Philippe Gabriel ;
Pocock, Stuart .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (19) :2224-2234
[2]   UNSTABLE ANGINA - A CLASSIFICATION [J].
BRAUNWALD, E .
CIRCULATION, 1989, 80 (02) :410-414
[3]   Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR) [J].
Buccheri, Sergio ;
James, Stefan ;
Lindholm, Daniel ;
Frobert, Ole ;
Olivecrona, Goran K. ;
Persson, Jonas ;
Hambraeus, Kristina ;
Witt, Nils ;
Erlinge, David ;
Angeras, Oskar ;
Lagerqvist, Bo ;
Sarno, Giovanna .
EUROPEAN HEART JOURNAL, 2019, 40 (31) :2607-2615
[4]   ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison [J].
Capodanno, Davide ;
Alfonso, Fernando ;
Levine, Glenn N. ;
Valgimigli, Marco ;
Angiolillo, Dominick J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (23) :2915-2931
[5]   Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months) [J].
Chevalier, Bernard ;
Smits, Pieter C. ;
Carrie, Didier ;
Mehilli, Julinda ;
Van Boven, Ad J. ;
Regar, Evelyn ;
Sawaya, Fadi J. ;
Chamie, Daniel ;
Kraaijeveld, Adriaan O. ;
Hovasse, Thomas ;
Vlachojannis, Georgios J. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (12)
[6]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[7]   Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial) [J].
De Luca, Giuseppe ;
Damen, Sander A. ;
Camaro, Cyril ;
Benit, Edouard ;
Verdoia, Monica ;
Rasoul, Saman ;
Liew, Houng Bang ;
Polad, Jawed ;
Ahmad, Wan A. ;
Zambahari, Robaayah ;
Postma, Sonja ;
Kedhi, Elvin ;
Suryapranata, Harry .
EUROINTERVENTION, 2019, 15 (11) :E990-+
[8]   Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial [J].
Feres, Fausto ;
Costa, Ricardo A. ;
Abizaid, Alexandre ;
Leon, Martin B. ;
Marin-Neto, J. Antonio ;
Botelho, Roberto V. ;
King, Spencer B., III ;
Negoita, Manuela ;
Liu, Minglei ;
de Paula, J. Eduardo T. ;
Mangione, Jose A. ;
Meireles, George X. ;
Castello, Helio J., Jr. ;
Nicolela, Eduardo L., Jr. ;
Perin, Marco A. ;
Devito, Fernando S. ;
Labrunie, Andre ;
Salvadori, Decio, Jr. ;
Gusmao, Marcos ;
Staico, Rodolfo ;
Costa, J. Ribamar ;
de Castro, Juliana P. ;
Abizaid, Andrea S. ;
Bhatt, Deepak L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23) :2510-2522
[9]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441
[10]   Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting [J].
Franzone, Anna ;
McFadden, Eugene ;
Leonardi, Sergio ;
Piccolo, Raffaele ;
Vranckx, Pascal ;
Serruys, Patrick W. ;
Benit, Edouard ;
Liebetrau, Christoph ;
Janssens, Luc ;
Ferrario, Maurizio ;
Zurakowski, Aleksander ;
Diletti, Roberto ;
Dominici, Marcello ;
Huber, Kurt ;
Slagboom, Ton ;
Buszman, Pawel ;
Bolognese, Leonardo ;
Tumscitz, Carlo ;
Bryniarski, Krzysztof ;
Aminian, Adel ;
Vrolix, Mathias ;
Petrov, Ivo ;
Garg, Scot ;
Naber, Christoph ;
Prokopczuk, Janusz ;
Hamm, Christian ;
Steg, Philippe Gabriel ;
Heg, Dik ;
Juni, Peter ;
Windecker, Stephan ;
Valgimigli, Marco .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (18) :2223-2234